213 related articles for article (PubMed ID: 28386046)
1. Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model.
Sociali G; Magnone M; Ravera S; Damonte P; Vigliarolo T; Von Holtey M; Vellone VG; Millo E; Caffa I; Cea M; Parenti MD; Del Rio A; Murone M; Mostoslavsky R; Grozio A; Nencioni A; Bruzzone S
FASEB J; 2017 Jul; 31(7):3138-3149. PubMed ID: 28386046
[TBL] [Abstract][Full Text] [Related]
2. SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells.
Sociali G; Grozio A; Caffa I; Schuster S; Becherini P; Damonte P; Sturla L; Fresia C; Passalacqua M; Mazzola F; Raffaelli N; Garten A; Kiess W; Cea M; Nencioni A; Bruzzone S
FASEB J; 2019 Mar; 33(3):3704-3717. PubMed ID: 30514106
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin 6, a possible therapeutic target for type 2 diabetes.
Bae EJ
Arch Pharm Res; 2017 Dec; 40(12):1380-1389. PubMed ID: 29177584
[TBL] [Abstract][Full Text] [Related]
4. Enhanced insulin sensitivity in skeletal muscle and liver by physiological overexpression of SIRT6.
Anderson JG; Ramadori G; Ioris RM; Galiè M; Berglund ED; Coate KC; Fujikawa T; Pucciarelli S; Moreschini B; Amici A; Andreani C; Coppari R
Mol Metab; 2015 Nov; 4(11):846-56. PubMed ID: 26629408
[TBL] [Abstract][Full Text] [Related]
5. High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects.
Yu J; Wu Y; Yang P
J Neurochem; 2016 May; 137(3):371-83. PubMed ID: 26896748
[TBL] [Abstract][Full Text] [Related]
6. Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics.
Sociali G; Galeno L; Parenti MD; Grozio A; Bauer I; Passalacqua M; Boero S; Donadini A; Millo E; Bellotti M; Sturla L; Damonte P; Puddu A; Ferroni C; Varchi G; Franceschi C; Ballestrero A; Poggi A; Bruzzone S; Nencioni A; Del Rio A
Eur J Med Chem; 2015 Sep; 102():530-9. PubMed ID: 26310895
[TBL] [Abstract][Full Text] [Related]
7. Myeloid Sirtuin 6 Deficiency Causes Insulin Resistance in High-Fat Diet-Fed Mice by Eliciting Macrophage Polarization Toward an M1 Phenotype.
Lee Y; Ka SO; Cha HN; Chae YN; Kim MK; Park SY; Bae EJ; Park BH
Diabetes; 2017 Oct; 66(10):2659-2668. PubMed ID: 28607107
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of high fat diet-induced glucose intolerance by blockade of Smad4 in pancreatic beta-cells.
Li HY; Oh YS; Lee YJ; Lee EK; Jung HS; Jun HS
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):221-6. PubMed ID: 25502579
[TBL] [Abstract][Full Text] [Related]
9. SIRT6 expression and oxidative DNA damage in individuals with prediabetes and type 2 diabetes mellitus.
Çalışkan Z; Mutlu T; Güven M; Tunçdemir M; Niyazioğlu M; Hacioglu Y; Dincer Y
Gene; 2018 Feb; 642():542-548. PubMed ID: 29197589
[TBL] [Abstract][Full Text] [Related]
10. SIRT6 regulates metabolic homeostasis in skeletal muscle through activation of AMPK.
Cui X; Yao L; Yang X; Gao Y; Fang F; Zhang J; Wang Q; Chang Y
Am J Physiol Endocrinol Metab; 2017 Oct; 313(4):E493-E505. PubMed ID: 28765271
[TBL] [Abstract][Full Text] [Related]
11. Streptozotocin-Treated High Fat Fed Mice: A New Type 2 Diabetes Model Used to Study Canagliflozin-Induced Alterations in Lipids and Lipoproteins.
Yu T; Sungelo MJ; Goldberg IJ; Wang H; Eckel RH
Horm Metab Res; 2017 May; 49(5):400-406. PubMed ID: 28395380
[TBL] [Abstract][Full Text] [Related]
12. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M
J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752
[TBL] [Abstract][Full Text] [Related]
13. SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects.
Damonte P; Sociali G; Parenti MD; Soncini D; Bauer I; Boero S; Grozio A; Holtey MV; Piacente F; Becherini P; Sanguineti R; Salis A; Damonte G; Cea M; Murone M; Poggi A; Nencioni A; Del Rio A; Bruzzone S
Bioorg Med Chem; 2017 Oct; 25(20):5849-5858. PubMed ID: 28958848
[TBL] [Abstract][Full Text] [Related]
14. A high-fat diet reverses metabolic disorders and premature aging by modulating insulin and IGF1 signaling in SIRT6 knockout mice.
Li Z; Xu K; Guo Y; Ping L; Gao Y; Qiu Y; Ni J; Liu Q; Wang Z
Aging Cell; 2020 Mar; 19(3):e13104. PubMed ID: 31967391
[TBL] [Abstract][Full Text] [Related]
15. Long-term obestatin treatment of mice type 2 diabetes increases insulin sensitivity and improves liver function.
Kołodziejski PA; Pruszyńska-Oszmałek E; Strowski MZ; Nowak KW
Endocrine; 2017 Jun; 56(3):538-550. PubMed ID: 28477305
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor.
Ka SO; Bang IH; Bae EJ; Park BH
FASEB J; 2017 Sep; 31(9):3999-4010. PubMed ID: 28536120
[TBL] [Abstract][Full Text] [Related]
17. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
18. SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes.
Wu X; Liu H; Brooks A; Xu S; Luo J; Steiner R; Mickelsen DM; Moravec CS; Jeffrey AD; Small EM; Jin ZG
Circ Res; 2022 Nov; 131(11):926-943. PubMed ID: 36278398
[TBL] [Abstract][Full Text] [Related]
19. Selenite exacerbates hepatic insulin resistance in mouse model of type 2 diabetes through oxidative stress-mediated JNK pathway.
Zhou J; Xu G; Bai Z; Li K; Yan J; Li F; Ma S; Xu H; Huang K
Toxicol Appl Pharmacol; 2015 Dec; 289(3):409-18. PubMed ID: 26522834
[TBL] [Abstract][Full Text] [Related]
20. A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice.
Gao LH; Liu Q; Liu SN; Chen ZY; Li CN; Lei L; Sun SJ; Li LY; Liu JL; Shen ZF
J Ethnopharmacol; 2014; 151(1):675-85. PubMed ID: 24286962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
